AWH - Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference | Benzinga
AUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that management will present a corporate overview at the MedInvest Biotech & Pharma Investor Conference taking place in New York City on April 3-4, 2024. Management will be available for one-on-one meetings with investors who are registered for the conference.
| Presentation Details: |
| Date: |
| Wednesday, April 3, 2024 |
| Time: |
| 4:20 pm EST |
| Webcast: |
| Recording of the presentation will be available after the event on Aspira's IR website |
| Registration: |
| Click HERE to register and attend the conference |
About MedInvest Biotech & Pharma Investor Conference
This two-day conference features presentations from more than 40 companies developing and/or commercializing technologies across a broad spectrum of indications – including oncology, immunology, neurology, cardiology, diabetes, infectious, pulmonary, autoimmune, respiratory diseases, urology, endocrinology, dermatology, pain management, and many others. The event also will feature talks from key industry ...